| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |